Related references
Note: Only part of the references are listed.A Review on the Arylpiperazine Derivatives as Potential Therapeutics for the Treatment of Various Neurological Disorders
Bhupinder Kumar et al.
CURRENT DRUG TARGETS (2022)
Design, Synthesis, and Pharmacological Evaluation of N-Propargylated Diphenylpyrimidines as Multitarget Directed Ligands for the Treatment of Alzheimer?s Disease
Bhupinder Kumar et al.
ACS CHEMICAL NEUROSCIENCE (2022)
Piperazine, a Key Substructure for Antidepressants: Its Role in Developments and Structure-Activity Relationships
Ravi Ranjan Kumar et al.
CHEMMEDCHEM (2021)
Investigation of Indole-3-piperazinyl Derivatives as Potential Antidepressants: Design, Synthesis, In-Vitro, In-Vivo and In-Silico Analysis
Ravi R. Kumar et al.
CHEMISTRYSELECT (2021)
Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: Synthesis, in-vivo, in-vitro and in-silico analysis
Devendra Kumar et al.
BIOORGANIC CHEMISTRY (2021)
Revitalizing monoamine oxidase inhibitors: a call for action
P. Ken Gillman et al.
CNS SPECTRUMS (2020)
Metal- and Solvent-Free Multicomponent Decarboxylative A3-Coupling for the Synthesis of Propargylamines: Experimental, Computational, and Biological Investigations
Pavneet Kaur et al.
JOURNAL OF ORGANIC CHEMISTRY (2020)
Synthesis and pharmacological evaluation of 3-[5-(aryl-[1,3,4]oxadiazole-2-yl]-piperidine derivatives as anticonvulsant and antidepressant agents
Ravi Bhushan Singh et al.
ARABIAN JOURNAL OF CHEMISTRY (2020)
Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase
Bhupinder Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease
Bhupinder Kumar et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Association of age with risk of major depression among patients with chronic kidney disease over midlife: a nationwide cohort study in Taiwan
Shih-Feng Chen et al.
INTERNATIONAL PSYCHOGERIATRICS (2019)
Reducing the global burden of depression: a Lancet-World Psychiatric Association Commission
Helen Herrman et al.
LANCET (2019)
Prevention of depression will only succeed when it is structurally embedded and targets big determinants
Johan Ormel et al.
WORLD PSYCHIATRY (2019)
Occurrence of the potent mutagens 2-nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles
Aldenor G. Santos et al.
SCIENTIFIC REPORTS (2019)
Synthesis and biological evaluation of pyrimidine bridged combretastatin derivatives as potential anticancer agents and mechanistic studies
Bhupinder Kumar et al.
BIOORGANIC CHEMISTRY (2018)
In vitro antioxidant activity of thiazolidinone derivatives of 1,3-thiazole and 1,3,4-thiadiazole
Mirjana Djukic et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence
F. Ferrari et al.
MOLECULAR NEUROBIOLOGY (2017)
Novel aryl piperazines for alleviation of 'andropause' associated prostatic disorders and depression
Sonal Gupta et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Piperazine derivatives for therapeutic use: a patent review (2010-present)
Anuj K. Rathi et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Investigation of antimalarial activity, cytotoxicity and action mechanism of piperazine derivatives of betulinic acid
Gloria N. S. Silva et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2015)
The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons
Pim Cuijpers et al.
WORLD PSYCHIATRY (2013)
Antidepressant potential of nitrogen-containing heterocyclic moieties: An updated review
Nadeem Siddiqui et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2011)
Prolactin-related and metabolic adverse effects of atypical antipsychotic agents
David C. Henderson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Three-dimensional structure of human monoamine oxidase A (MAO A): Relation to the structures of rat MAO A and human MAO B
L De Colibus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Antioxidative activities of novel diphenylalkyl piperazine derivatives with high affinities for the dopamine transporter
M Kimura et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents:: A combined neurochemical and behavioral analysis
MJ Millan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Excess mortality in bipolar and unipolar disorder in Sweden
U Ösby et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Share Paper
